Albuterol Sulfate Aerosol, Metered
Product Images NDC 45802-088

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Albuterol Sulfate (NDC 45802-088). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Chemical Structure)

FDA Label Image

Figure-a-b.jpg (Figure A B)

Figure-a-b.jpg (Figure A B)
The text describes a metal canister with a dose counter. The canister is likely used to store medication or other substances that require precise dosing. The document includes two figures labeled as Figure A and Figure B, but further information about these figures is not provided.*
FDA Label Image

Figure-c.jpg (Figure C)

FDA Label Image

Figure-d.jpg (Figure D)

Figure-d.jpg (Figure D)
This text provides information on the Albuterol Sulfate Inhalation Aerosol, which comes with 200 sprays for use and an additional 3 sprays meant for priming. The text also explains that the spray counter on the device displays 200 before priming and 203 after priming. A figure labeled "Figure D" may be presented along with this text.*
FDA Label Image

Figure-e.jpg (Figure E)

FDA Label Image

Figure-f.jpg (Figure F)

FDA Label Image

Figure-g-h.jpg (Figure G H)

Figure-g-h.jpg (Figure G H)
Not available.*
FDA Label Image

Figure-graphs (Figure Graphs)

Figure-graphs (Figure Graphs)
This is a report on a clinical trial that measures the mean percent change from test-day pre-dose in FEV (forced expiratory volume) at different time intervals (hours) over the course of 6 weeks. The trial involved three groups: one using albuterol sulfate inhalation aerosol, one using a matched placebo HFA inhalation aerosol, and one using a marketed HFA-134a albuterol inhaler. The number of participants in each group fluctuates slightly throughout the trial.*
FDA Label Image

Figure-i.jpg (Figure I)

FDA Label Image

Figure-j.jpg (Figure J)

FDA Label Image

Figure-k.jpg (Figure K)

Figure-k.jpg (Figure K)
Not available.*
FDA Label Image

Image 01

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.